A Dallas healthcare company is assembling a team of experts to tackle one of the biggest hurdles in achieving longevity: cancer.
Cancer Check Labs announced the formation of its Longevity & Wellness Advisory Council. The company, which specializes in early cancer detection technology, aims to leverage the council’s expertise to enhance its screening methods and promote effective wellness strategies. Cancer Check Labs develops a blood test called Cancer Check, which it says can screen for over 200 types of cancer by extracting circulating tumor cells from a blood sample. According to the company, because CTCs have been detected in blood samples as early as Stage 0, Cancer Check “arguably provides the earliest cancer detection test available today.”
According to Sumit Rai, CEO of Cancer Check Labs, “Cancer is a pivotal factor in the pursuit of longevity due to the complex challenges in early detection to intervene earlier.” Rai, who brings over 20 years of experience in venture capital, private equity, and hedge funds to his role, founded the company after losing his sister to cancer about 14 years ago.
Cancer Check Labs has invested $80 million over the years to develop a proprietary filter that can process a significant volume of blood and detect circulating tumor cells, D CEO reported earlier this year.
The newly formed Longevity & Wellness Advisory Council will be instrumental in shaping the company’s approach to “early cancer detection, cancer prevention, and advancing innovative solutions that tackle this challenge head-on,” Rai said in a statement. The council brings together seven professionals from various sectors of healthcare and wellness:
- Dr. Joseph Cleaver, chairman of the council and a fellow of the American Board of Anti-Aging/Regenerative Medicine
- Dr. Anthony Harris, Amazon’s Global Medical Director
- Gillian Plummer, Director of Wellness at Quest Diagnostics
- Dr. Andrew Heyman, leader of the Integrative and Metabolic Medicine Center at The George Washington University
- Dr. Elliott B. Lander, co-founder of the California Stem Cell Treatment Center
- Dr. Mark Carney, a naturopathic doctor and public speaker on holistic medicine
- Dr. Christopher Chun, owner of Epic Pain & Orthopedics
“Cancer is now the foremost focus in longevity,” said Dr. Josephe Cleaver, who is chairman of the council. “I’m honored to lead this esteemed group and collaborate with Sumit in advancing the best early detection solutions.”
While Cancer Check Labs touts its technology’s potential in early detection, the company says its test is not intended to replace other established cancer screening methods, and notes that the test not been cleared or approved by the Food and Drug Administration.
The council’s key objectives include promoting wellness practices that support overall longevity and raising public awareness about the importance of early cancer detection. With cancer affecting 40% of the population, according to Cancer Check Labs, the company sees addressing this disease as crucial to achieving lasting health.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
The UT Southwestern researchers' noninvasive model uses a standard MRI, paired with machine learning AI, to detect the presence of cancer cells in the lymph nodes under the arms.
-
As part of a nationwide effort, the NFEC chose Texas as one of its initial launch states because of the demonstrated need for greater economic empowerment among Texans.
-
In a boost for bioentrepreneurs, the American Cancer Society’s BrightEdge has unveiled its new BrightEdge Entrepreneurs program. Aimed at accelerating the transition of cancer-focused innovations from research labs to the healthcare market, the program is set to begin on February 5, 2024. The 10-month initiative will support a cohort of 6 to 8 entrepreneurs, providing them with essential training, mentorship, and funding. The program targets scientific innovators who are ready to take their preliminary business ideas and develop them into viable companies dedicated to cancer diagnostics, therapeutics, medical devices, and digital health solutions. BrightEdge Entrepreneurs offers a rigorous curriculum addressing…
-
Included in the 12 Dallas-area funding awards is a $4 million Rising Star grant to bring Stefan Gloeggler, Ph.D., to UT Southwestern Medical Center from the Max Planck Institute of Multidisciplinary Sciences in Göttingen, Germany.
-
Researchers at Children's Hospital of Philadelphia and UT Southwestern analyzed T-cell receptors in nearly 500 blood samples from pre-diagnostic patients with ovarian cancer. The results point to the potential of testing for biomarkers 2 to 4 years before most cases of HGOC are currently diagnosed.
